BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27721414)

  • 1. Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis.
    Pan X; Bradfield CA; Hussain MM
    Nat Commun; 2016 Oct; 7():13011. PubMed ID: 27721414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.
    Sberna AL; Assem M; Gautier T; Grober J; Guiu B; Jeannin A; Pais de Barros JP; Athias A; Lagrost L; Masson D
    J Hepatol; 2011 Jul; 55(1):154-61. PubMed ID: 21145854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.
    Yu XH; Qian K; Jiang N; Zheng XL; Cayabyab FS; Tang CK
    Clin Chim Acta; 2014 Jan; 428():82-8. PubMed ID: 24252657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmal1 regulates production of larger lipoproteins by modulating cAMP-responsive element-binding protein H and apolipoprotein AIV.
    Pan X; Hussain MM
    Hepatology; 2022 Jul; 76(1):78-93. PubMed ID: 34626126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
    Dikkers A; de Boer JF; Groen AK; Tietge UJ
    Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
    Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
    Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8.
    Sumi K; Tanaka T; Uchida A; Magoori K; Urashima Y; Ohashi R; Ohguchi H; Okamura M; Kudo H; Daigo K; Maejima T; Kojima N; Sakakibara I; Jiang S; Hasegawa G; Kim I; Osborne TF; Naito M; Gonzalez FJ; Hamakubo T; Kodama T; Sakai J
    Mol Cell Biol; 2007 Jun; 27(12):4248-60. PubMed ID: 17403900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
    Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
    Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
    Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.
    Yu L; Li-Hawkins J; Hammer RE; Berge KE; Horton JD; Cohen JC; Hobbs HH
    J Clin Invest; 2002 Sep; 110(5):671-80. PubMed ID: 12208868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
    Kamisako T; Ogawa H; Yamamoto K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
    Altemus JB; Patel SB; Sehayek E
    Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pravastatin and bezafibrate on biliary lipid excretion and hepatic expression of Abcg5 and Abcg8 in the rat.
    Kamisako T; Ogawa H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):879-83. PubMed ID: 15242490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
    Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
    Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion.
    Yu L; Hammer RE; Li-Hawkins J; Von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16237-42. PubMed ID: 12444248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.
    Oiwa A; Kakizawa T; Miyamoto T; Yamashita K; Jiang W; Takeda T; Suzuki S; Hashizume K
    Biochem Biophys Res Commun; 2007 Feb; 353(4):895-901. PubMed ID: 17204240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
    Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
    Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
    Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.